Porosity optimization confers 3D-printed porous tantalum scaffolds with superior osteogenic capability and biocompatibility over titanium alloys Authors: Yuqi Liang, Jing Han, Zhengcheng Wang, Desheng Chen, Zhigang Bai, Cong Wang Published: 2025 ABSTRACT ObjectiveThis study aimed to compare the osseointegration capacity, biocompatibility, and inflammatory response of 3D-printed tantalum (Ta) and titanium alloy (Ti) scaffolds, with a specific focus on isolating the effect of intrinsic material properties by employing identical pore sizes (200–1000 μm) and porosities (25–95%).MethodsTa and Ti scaffolds with controlled pore sizes and porosities were fabricated using 3D printing. Their physicochemical properties and biological performance were systematically evaluated to compare the two materials under architecturally identical conditions.ResultsThe key finding was that the material composition itself, independent of pore architecture, was a predominant factor governing cellular responses. While both materials supported osteogenesis, Ta scaffolds demonstrated superior osteogenic differentiation, mineralization, and cell adhesion at matched porosities and pore sizes. Gene expression analysis revealed that Ta promoted higher expression of key osteogenic markers (Runx2, Sp7, Bglap), whereas Ti scaffolds showed higher expression of Ctnnb1 and Axin2 and a slightly better anti-inflammatory profile. High porosity (85%, 95%) was generally beneficial for osteogenic activity in both materials.ConclusionThe study demonstrates that the intrinsic properties of Ta and Ti significantly influence their biological performance beyond the effects of porosity and pore size. Ta exhibits superior overall osteogenic potential and cell adhesion, making it a promising candidate for orthopedic coatings. This direct comparison under identical topological conditions provides crucial insights for selecting and optimizing base materials for prosthetic implants.Trial registrationThis study is a computer simulation/in vitro cell experiment/data analysis study, and does not involve human or animal experiments.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13018-025-06577-3. Introduction Total hip arthroplasty (THA) effectively treats hip joint diseases, improving outcomes for many. Recent research show annual hip replacement surgeries are increasing by years [1]. While this leads to more complications, aseptic loosening is the most common failure. Many orthopedic surgeons now prefer biological fixation prostheses, which use surface coatings for better long-term outcomes and bone ingrowth than cemented prostheses. Titanium alloy remains the primary medical metal for its low elastic modulus, corrosion resistance, and biocompatibility [2]. However, new research highlights tantalum's excellent elastic modulus, strength, biocompatibility, and tissue ingrowth, giving it advantages in biological fixation [3, 4]. 3D printing supports personalized treatment, enabling biomimetic trabecular implants with microporous structures that enhance bone ingrowth [5]. Systematic comparative studies of biocompatibility and osteogenic performance between metals like Ta and Ti alloy with the same pore characteristics are still lacking. Materials and methods Cell culture Human bone marrow mesenchymal stem cells (hBMMSCs) (purchased from iCell, Cat. No. HUM-iCell-m031-s011) and MC3T3-E1 cells (purchased from iCell, Cat. No. iCell-m031) were cultured in hBMMSC-specific medium (purchased from iCell, Cat. No. iCell-s011-002h) and MC3T3-E1-specific medium (purchased from iCell, Cat. No. iCell-m031-001b), respectively. The cells were maintained in a constant temperature and humidity incubator at 37 °C with 5% CO2. When cell confluence reached 80–90%, they were digested with 0.25% Trypsin–EDTA (Gibco, 25200056) for 2–3 min. The digestion was then terminated by adding complete medium. The cell suspension was centrifuged at 1000 rpm for 5 min. After discarding the supernatant, the cell pellet was resuspended in fresh complete medium for subsequent passaging or counting for experiments. For cell cryopreservation, the centrifuged cell pellet was resuspended in cell freezing medium (10% DMSO (Sigma, D2650) + 90% FBS), transferred into cryovials, and placed in a programmable freezing container. The vials were stored at − 80 °C overnight before being transferred to liquid nitrogen for long-term storage. Scaffold preparation Using 3D printing technology, we fabricated five groups of titanium alloy and tantalum metal scaffolds with designed pore sizes of 200 μm, 400 μm,600 μm,800 μm and 1000 μm, and porosities of 25%, 55%, 75%, 85% and 95%. To facilitate subsequent in vitro experiments, we designed disc-shaped scaffolds (dimensions: 3 mm in diameter, 10 mm in height) for cell studies and cylindrical scaffolds (dimensions: 6 mm in diameter, 10 mm in height) for physicochemical characterization. Osteogenic differentiation The 3D-printed titanium/tantalum scaffolds, sterilized by ultraviolet irradiation for 30 min, were placed in 24-well plates and coated with 0.1% gelatin (Gelatin from bovine skin, Sigma, G9391) for 1 h. Cells in the logarithmic growth phase were digested, collected, resuspended in complete proliferation medium, and counted. They were then seeded into the 24-well plates at a density of 2 × 104 cells/well (including experimental groups with scaffolds and control groups without scaffolds), with 0.5 ml of medium added to each well. When cell confluence reached 60–70%, the medium was carefully aspirated and replaced with osteogenic induction medium. The induction medium was refreshed every 3 days, and the cells were induced for 14 days followed by subsequent assays. Alkaline phosphatase (ALP) staining After 14 days of induction culture, the medium was discarded, and the cells were gently washed twice with PBS. Then, 1 mL of 4% paraformaldehyde (in PBS) was added to each well to fix the cells at room temperature for 15 min. After removing the fixative, the cells were washed three times with PBS, each wash lasting 5 min. The working solution was prepared using a BCIP/NBT Alkaline Phosphatase Color Development Kit. An appropriate amount of the working solution was added to each well (ensuring complete coverage of the samples), followed by incubation at room temperature protected from light for 30 min (the incubation time could be adjusted based on the degree of color development). The reaction was terminated by washing twice with distilled water. After air-drying at room temperature, the samples were observed and photographed under a microscope. Quantitative analysis was performed using ImageJ software by measuring the mean gray value of each well for statistical analysis (Fig. 1).Fig. 13D printing metal bracket model 3D printing metal bracket model Alizarin Red S Staining After induction, the cells were fixed with 4% paraformaldehyde and washed with PBS following the method described above. Then, 1 mL of 40 mM Alizarin Red S solution was added to each well, and the cells were stained at room temperature for 30 min. After discarding the staining solution, the cells were gently washed 4–5 times with deionized water (ddH2O) until the background became colorless. Next, 1 mL of PBS was added to each well to prevent drying. Red calcium nodules were observed and photographed under a microscope. Quantification of calcium nodules was performed using ImageJ software: images were converted to RGB stacks, the red channel was extracted, a uniform threshold was set to binarize the calcium nodule areas, and the percentage of positively stained area relative to the total area was calculated. Cell adhesion assay The sterilized metal scaffolds were placed in a 48-well plate. MC3T3-E1 and hBMMSCs before osteogenic induction were digested with trypsin, resuspended, and adjusted to a cell density of 2 × 105 cells/mL. Then, 1 mL of cell suspension (i.e., 2 × 105 cells/well) was added to each well (including experimental wells with scaffolds and control wells in a standard 48-well cell culture plate without scaffolds). The plates were placed in an incubator and cultured for 2 h and 4 h, respectively, to assess initial adhesion. At the predetermined time points, the culture medium was carefully aspirated, and the wells were gently rinsed three times with pre-warmed PBS to remove non-adherent cells. Next, 500 μL of serum-free basal medium and 50 μL of CCK-8 reagent (Dojindo, Japan) were added to each well. After gentle shaking, the plates were further incubated for 2 h. After incubation, 200 μL of liquid from each well was transferred to a 96-well plate, and the absorbance (OD value) was measured at a wavelength of 450 nm using a microplate reader. The cell adhesion rate was calculated as follows: Adhesion Rate (%) = (OD experimental group/OD control group) × 100%. PCR detection RNA extraction Total RNA was extracted from cells using TRIzol Reagent (Invitrogen, 15596026) according to the manufacturer’s instructions. The specific procedure was as follows:For every 5–10 × 106 cells, 1 mL of TRIzol was added, and the cells were lysed completely by gentle pipetting several times, followed by incubation at room temperature for 5 min.0.2 mL of chloroform was added per 1 mL of TRIzol used. The mixture was vigorously shaken for 15 s and then incubated at room temperature for 2–3 min.The sample was centrifuged at 12,000 × g at 4 °C for 15 min. Approximately 0.3 mL of the upper colorless aqueous phase was transferred to a new sterile, RNase-free 1.5 mL microcentrifuge tube.0.3 mL of isopropanol was added, mixed thoroughly, and incubated at room temperature for 10 min.The sample was centrifuged at 12,000 × g at 4 °C for 10 min.The supernatant was discarded, and the RNA pellet was washed with 1 mL of ice-cold 75% ethanol (prepared with DEPC-treated water).The sample was centrifuged again at 12,000 × g at 4 °C for 5 min.Steps 6 and 7 were repeated once.The supernatant was carefully removed, and the tube was left uncapped to air-dry at room temperature for 3–5 min.20–50 μL of DEPC-treated water was added, and the RNA was dissolvedcompletely by incubating at 4 °C for 30 min.The RNA concentration and purity were measured using a nucleic acid quantification device.The RNA was stored at − 80 °C for long-term preservation. For every 5–10 × 106 cells, 1 mL of TRIzol was added, and the cells were lysed completely by gentle pipetting several times, followed by incubation at room temperature for 5 min. For every 5–10 × 106 cells, 1 mL of TRIzol was added, and the cells were lysed completely by gentle pipetting several times, followed by incubation at room temperature for 5 min. 0.2 mL of chloroform was added per 1 mL of TRIzol used. The mixture was vigorously shaken for 15 s and then incubated at room temperature for 2–3 min. 0.2 mL of chloroform was added per 1 mL of TRIzol used. The mixture was vigorously shaken for 15 s and then incubated at room temperature for 2–3 min. The sample was centrifuged at 12,000 × g at 4 °C for 15 min. Approximately 0.3 mL of the upper colorless aqueous phase was transferred to a new sterile, RNase-free 1.5 mL microcentrifuge tube. The sample was centrifuged at 12,000 × g at 4 °C for 15 min. Approximately 0.3 mL of the upper colorless aqueous phase was transferred to a new sterile, RNase-free 1.5 mL microcentrifuge tube. 0.3 mL of isopropanol was added, mixed thoroughly, and incubated at room temperature for 10 min. 0.3 mL of isopropanol was added, mixed thoroughly, and incubated at room temperature for 10 min. The sample was centrifuged at 12,000 × g at 4 °C for 10 min. The sample was centrifuged at 12,000 × g at 4 °C for 10 min. The supernatant was discarded, and the RNA pellet was washed with 1 mL of ice-cold 75% ethanol (prepared with DEPC-treated water). The supernatant was discarded, and the RNA pellet was washed with 1 mL of ice-cold 75% ethanol (prepared with DEPC-treated water). The sample was centrifuged again at 12,000 × g at 4 °C for 5 min. The sample was centrifuged again at 12,000 × g at 4 °C for 5 min. Steps 6 and 7 were repeated once. Steps 6 and 7 were repeated once. The supernatant was carefully removed, and the tube was left uncapped to air-dry at room temperature for 3–5 min. The supernatant was carefully removed, and the tube was left uncapped to air-dry at room temperature for 3–5 min. 20–50 μL of DEPC-treated water was added, and the RNA was dissolvedcompletely by incubating at 4 °C for 30 min. 20–50 μL of DEPC-treated water was added, and the RNA was dissolvedcompletely by incubating at 4 °C for 30 min. The RNA concentration and purity were measured using a nucleic acid quantification device. The RNA concentration and purity were measured using a nucleic acid quantification device. The RNA was stored at − 80 °C for long-term preservation. The RNA was stored at − 80 °C for long-term preservation. Reverse transcription RNA samples were aliquoted into sterile, RNase-free 0.2–1.0 mL microcentrifuge tubes. The reaction mixture was prepared on ice according to the following components and distributed into each reaction tube. After gentle mixing and brief centrifugation, the tubes were incubated in a 42 °C water bath for 15 min. Finally, the reaction was terminated by heating at 85 °C for 5 s to inactivate TransScript RT/RI and gDNA Remover (Table 1).Table 1Reverse transcription reagent materialComponentVolumeTotal RNA ≤ 0.5 μg5 × TransScriptB All-in-One SuperMix for qPCR2 μlgDNA remover0.5 μlRNase free waterup to 10.0 μl Table 1Reverse transcription reagent materialComponentVolumeTotal RNA ≤ 0.5 μg5 × TransScriptB All-in-One SuperMix for qPCR2 μlgDNA remover0.5 μlRNase free waterup to 10.0 μl Reverse transcription reagent material Quantitative real-time PCR (qPCR) Following reverse transcription, the cDNA was diluted fivefold using RNase-Free Water. For the quantitative PCR reaction, 1.0 µL of the diluted cDNA solution was added per 10 µL reaction volume. Reactions were performed in 384-well plates with a total volume of 10 µL per well. Primers were pre-dissolved and prepared as 10 µM stock solutions. The master mix was prepared according to the manufacturer's instructions of the qPCR kit. The master mix and cDNA were then separately dispensed into the PCR plate. After sealing, the plate was briefly centrifuged and subjected to detection. The qPCR cycling protocol was set as follows: initial denaturation at 94 °C for 30 s; followed by 40 cycles of denaturation at 94 °C for 5 s and annealing/extension at 60 °C for 30 s (with signal acquisition). After the amplification cycles, a melting curve analysis was performed: the temperature was increased to 95 °C at a rate of 1.6 °C per second and held for 15 s; then decreased to 60 °C at a rate of 1.6 °C per second and held for 1 min; finally, the temperature was slowly raised to 95 °C at a rate of 0.05 °C per second (with continuous signal acquisition during this stage), followed by a final hold at 95 °C for 15 s. The genes detected include: Runx2, Bglap, RANKL, OPG, TNF-α, IL-1β,β-catenin, and Axin2. The corresponding primer sequences are listed in the figure below (Tables 2, 3, 4).Table 2Detection of genes and sequences by PCRPrimer nameSequence (5′ to 3′)Tnfsf11-mFCAGCATCGCTCTGTTCCTGTATnfsf11-mRCTGCGTTTTCATGGAGTCTCATnfrsf11b-mFACCCAGAAACTGGTCATCAGCTnfrsf11b-mRCTGCAATACACACACTCATCACTBglap-mFCTTGGCCCAGACCTAGCAGABglap-mRATAGCTCGTCACAAGCAGGGPtgs2-mFTTCAACACACTCTATCACTGGCPtgs2-mRAGAAGCGTTTGCGGTACTCATCtnnb1-mFATGGAGCCGGACAGAAAAGCCtnnb1-mRCTTGCCACTCAGGGAAGGAAxin2-mFTGACTCTCCTTCCAGATCCCAAxin2-mRTGCCCACACTAGGCTGACARunx2-mFTTCAACGATCTGAGATTTGTGGGRunx2-mRGGATGAGGAATGCGCCCTASp7-mFATGGCGTCCTCTCTGCTTGSp7-mRTGAAAGGTCAGCGTATGGCTTIl1b-mFGCAACTGTTCCTGAACTCAACTIl1b-mRATCTTTTGGGGTCCGTCAACTTnf-mFCCTGTAGCCCACGTCGTAGTnf-mRGGGAGTAGACAAGGTACAACCCTable 3Experimental instruments and equipmentInstruments and equipmentBrandModelBiological safety cabinetThermo Fisher Scientific (USA)1379CO2 incubatorThermo Fisher Scientific (USA)Thermo Forma 311Inverted microscopeOLYMPUS (Japan)CKX 53 − 80 °C Ultra-low temperature freezerQingdao Haier Biomedical Co., Ltd. (China)Haier-DW-86L338JBenchtop low-speed CentrifugeShanghai Tomos Scientific Instrument Co., Ltd2–6Benchtop high-speed refrigerated centrifugeShanghai Tomos Scientific Instrument Co., Ltd1-16RUltra-micro spectrophotometerHangzhou Youning Instrument Co., LtdNANO-ONEReal-time PCR systemApplied Biosystems (ABI, USA)ViiATM7Table 4Experimental reagentReagent/materialManufacturerCatalog numberhBMMSCsiCellHUM-iCell-s011MC3T3-E1 celliCelliCell-m031hBMMSCs MediumiCelliCell-s011-002hMC3T3-E1 Specific MediumiCelliCell-m031-001bhBMMSCs Osteogenic Induction KitCyagenHUXMX-90021MC3T3-E1 Osteogenic Induction KitCyagenHUXMT-90021Trypsin–EDTAGibco2520056TRIzol ReagentInvitrogen15596026ALL-in-one First-strand cDNA SynthesisTransgeneAT341superMix for qPCR Perfect®Green qPCR SuperMixTransgeneAQ602Alkaline Phosphatase Staining KitBeyotimeC3250SAlizarin Red S Staining SolutionCyagenALIR-10001General Laboratory Consumables (tips, microtubes, etc.)AxgenCell Culture Consumables (dishes, plates, pipettes, centrifuge tubes, etc.)Coming Table 2Detection of genes and sequences by PCRPrimer nameSequence (5′ to 3′)Tnfsf11-mFCAGCATCGCTCTGTTCCTGTATnfsf11-mRCTGCGTTTTCATGGAGTCTCATnfrsf11b-mFACCCAGAAACTGGTCATCAGCTnfrsf11b-mRCTGCAATACACACACTCATCACTBglap-mFCTTGGCCCAGACCTAGCAGABglap-mRATAGCTCGTCACAAGCAGGGPtgs2-mFTTCAACACACTCTATCACTGGCPtgs2-mRAGAAGCGTTTGCGGTACTCATCtnnb1-mFATGGAGCCGGACAGAAAAGCCtnnb1-mRCTTGCCACTCAGGGAAGGAAxin2-mFTGACTCTCCTTCCAGATCCCAAxin2-mRTGCCCACACTAGGCTGACARunx2-mFTTCAACGATCTGAGATTTGTGGGRunx2-mRGGATGAGGAATGCGCCCTASp7-mFATGGCGTCCTCTCTGCTTGSp7-mRTGAAAGGTCAGCGTATGGCTTIl1b-mFGCAACTGTTCCTGAACTCAACTIl1b-mRATCTTTTGGGGTCCGTCAACTTnf-mFCCTGTAGCCCACGTCGTAGTnf-mRGGGAGTAGACAAGGTACAACCC Detection of genes and sequences by PCR Table 3Experimental instruments and equipmentInstruments and equipmentBrandModelBiological safety cabinetThermo Fisher Scientific (USA)1379CO2 incubatorThermo Fisher Scientific (USA)Thermo Forma 311Inverted microscopeOLYMPUS (Japan)CKX 53 − 80 °C Ultra-low temperature freezerQingdao Haier Biomedical Co., Ltd. (China)Haier-DW-86L338JBenchtop low-speed CentrifugeShanghai Tomos Scientific Instrument Co., Ltd2–6Benchtop high-speed refrigerated centrifugeShanghai Tomos Scientific Instrument Co., Ltd1-16RUltra-micro spectrophotometerHangzhou Youning Instrument Co., LtdNANO-ONEReal-time PCR systemApplied Biosystems (ABI, USA)ViiATM7 Experimental instruments and equipment Table 4Experimental reagentReagent/materialManufacturerCatalog numberhBMMSCsiCellHUM-iCell-s011MC3T3-E1 celliCelliCell-m031hBMMSCs MediumiCelliCell-s011-002hMC3T3-E1 Specific MediumiCelliCell-m031-001bhBMMSCs Osteogenic Induction KitCyagenHUXMX-90021MC3T3-E1 Osteogenic Induction KitCyagenHUXMT-90021Trypsin–EDTAGibco2520056TRIzol ReagentInvitrogen15596026ALL-in-one First-strand cDNA SynthesisTransgeneAT341superMix for qPCR Perfect®Green qPCR SuperMixTransgeneAQ602Alkaline Phosphatase Staining KitBeyotimeC3250SAlizarin Red S Staining SolutionCyagenALIR-10001General Laboratory Consumables (tips, microtubes, etc.)AxgenCell Culture Consumables (dishes, plates, pipettes, centrifuge tubes, etc.)Coming Experimental reagent Results Alkaline phosphatase (ALP) staining Analysis of ALP expression, an early marker of osteogenic differentiation, revealed that scaffold porosity and material composition significantly influenced cellular activity. Effect of porosity For both titanium (Ti) and tantalum (Ta) scaffolds, groups with high porosity (85% and 95%) consistently exhibited stronger ALP staining compared to low porosity (25% and 55%) groups in both hBMMSC and MC3T3-E1 cell cultures (Fig. 2).Fig. 2ALP staining results ALP staining results Effect of material At equivalent porosity levels, Ta scaffolds demonstrated markedly higher relative ALP expression than Ti scaffolds. The Ta-85 group showed the more pronounced ALP activity with hBMMSCs among other groups,Ta-95 is close to Ti 95 in the expression of ME3T3E1 (Fig. 2). Alizarin Red S Staining The formation of mineralized nodules, assessed by Alizarin Red S (ARS) staining, was used to evaluate late-stage osteogenic differentiation and mineralization. Effect of porosity and material ARS staining intensity generally increased with higher porosity in both Ti and Ta scaffolds (Fig. 3). Notably, Ta scaffolds promoted significantly greater mineralization than Ti scaffolds at matched porosities. The Ta-85 group, in particular, showed the highest relative expression of mineralized nodules in hBMMSCs (Fig. 3).Fig. 3ARS staining results ARS staining results PCR gene expression analysis The melt curve analysis confirmed the specificity of all primers used. The expression of osteogenesis-, osteoclastogenesis-, and inflammation-related genes was quantified. Osteogenesis-related genes The expression of key osteogenic genes was upregulated in high-porosity groups (85%, 95%) for both materials (Fig. 4).Fig. 4PCR amplification results PCR amplification results Ctnnb1 & Axin2: Ta scaffolds, particularly in the medium to high porosity range (75%-95%), showed superior or comparable expression to Ti scaffolds. Runx2: High porosity promoted Runx2 expression in both materials. The Ti-85 group exhibited a prominent peak in expression, which was higher than that observed in Ta scaffolds at high porosity (Fig. 4). Sp7 & Bglap: Ta scaffolds consistently induced higher expression of these mid-to-late osteogenic markers than Ti scaffolds across multiple porosity levels, with the highest values often seen in the Ta-95 group (Fig. 4). Bone remodeling and inflammatory genes Tnfsf11 (RANKL) & Tnfrsf11b (OPG): The expression of both genes was elevated in high-porosity scaffolds. The RANKL/OPG ratio, a key indicator of bone resorption activity, was found to be comparable between the two metals. Inflammatory Markers (Tnf-α & IL-1β): Lower gene expression levels were associated with 25% and 75% porosity in both materials. While IL-1β expression was generally lower on Ti scaffolds under identical conditions, no consistent material-dependent difference was observed for Tnf-α (Fig. 4). Cell adhesion rate Cell adhesion was significantly enhanced on high-porosity scaffolds. The Ta-95% and Ti-95% groups achieved the highest cell adhesion rates, with the Ta-95% group showing the highest overall value. Chart making We use Graphpad prism (Graphpad Software, San Diego, CA) to make charts. Discussion The development of orthopedic implant materials has long been a key research focus in the field of biomedical engineering. Among these materials, titanium alloys are regarded as the mainstream choice for orthopedic implants [1]. However, their osseointegration capacity is limited. Tantalum, as a bioinert metal, has demonstrated favorable outcomes in human studies [5, 6]. Traditional manufacturing techniques face challenges in precisely controlling the pore size, porosity, and complex three-dimensional architecture of porous scaffolds. Consequently, optimizing the porous structure is a crucial strategy for enhancing the osseointegration performance of metal implants. Nevertheless, the specific influence of these structural parameters on the osteogenic behavior of different materials remains unclear.Through a systematic comparison of 3D-printed tantalum and titanium alloy scaffolds, this study revealed that although high porosity and large pore size generally enhance osteogenic activity, the material's intrinsic properties predominantly dictate the cellular response pattern. Tantalum demonstrated superior performance in promoting osteogenic differentiation, mineralization, and cell adhesion, whereas titanium exhibited specific advantages in the expression of some early osteogenic genes and anti-inflammatory response (Figs. 5, 6).Fig. 5PCR amplification resultsFig. 6Cell adsorption experiment PCR amplification results Cell adsorption experiment Pore size and porosity are critical factors influencing the osseointegration of porous scaffolds [7, 8]. Large pore sizes and high porosity can promote the ingrowth of vascular tissue into the scaffold, facilitating vascularized osteogenesis. However, this is accompanied by a sharp decline in mechanical properties and a reduction in cell adhesion sites, which is detrimental to cell proliferation. Hulbert SF et al. were among the first to propose that the pore size of bone implant materials must be at least 100 μm to meet the basic requirements for bone tissue ingrowth [9]. When the pore size reaches 1000 μm, the compressive strength and fatigue resistance of the scaffold significantly decrease [10]. Porous structures facilitate the transport and circulation of nutrients and bodily fluids, enhancing the short-term stability of the implant. Therefore, the pore size range for most multi-porous scaffolds typically falls between 100 and 1000 μm. Porous metals with pore sizes between 400 and 600 μm can promote osteogenic adsorption capacity, proliferation, osteogenic differentiation, and better osseointegration capability [11]. The strongest osteogenic differentiation capacity, as detected using human periosteum-derived cells, was observed at a pore size of 500 μm and 80% porosity [12, 13]. When co-cultured with BMMSCs, porous tantalum showed no inhibitory effect on BMMSC adsorption [14]. Currently, comparative studies evaluating these two metals across different pore sizes and porosities are scarce. Our experiments found that metal scaffolds with high porosity (85%, 95%) and large pore sizes (800–1000 μm) exhibited superior osteogenic capability compared to those with low porosity, which was further confirmed by related PCR gene amplification results. Cell adhesion assays also further demonstrated that scaffolds with high porosity provide a better microenvironment for cell attachment. Osseointegration capacity is one of the core indicators for evaluating the performance of orthopedic implant materials, directly impacting the long-term stability and clinical success of the implant. Albrektsson et al. summarized four major factors affecting bone-implant integration: the implant material, design, biocompatibility, and surface properties [15]. The condition of the implant primarily refers to its in vivo activity, load-bearing situation, and surgical technique. These principles remain fundamental to modern implantology. Among the factors influencing implant osseointegration, macroscopic design and implantation technique play vital roles. How to continuously optimize these aspects to further enhance and improve their clinical application has become a significant scientific question with substantial application value. Our in vitro experiments, utilizing hBMMSC and MC3T3-E1 cell models, confirmed that porous tantalum scaffolds are superior to titanium in promoting osteogenic differentiation. ALP is a key marker for early differentiation and is positively correlated with bone collagen formation [16]. Our study found that ALP levels associated with tantalum scaffolds were higher than those with titanium in both cell types, with the Ta-95% group showing particularly pronounced. Following the initiation of early osteogenic differentiation by the metal scaffolds, mineralization deposition capability is a critical subsequent step. We found that ARS staining, indicating mineralization, was higher in tantalum scaffolds compared to titanium when cultured with bone marrow mesenchymal stem cells, with the Ta-85% group showing the highest relative expression in hBMMSCs. Overall, Ta scaffolds, especially those with high porosity (85% and 95%), demonstrated a strong ability to promote mineralization. The overall culture of MC3T3-E1 cells further confirmed the strong osteogenic potential of tantalum scaffolds, particularly at higher porosity levels. A prerequisite for successful osteogenesis is the ability of cells to adhere to the scaffold. The cell adhesion assays consistently showed higher adhesion on tantalum than on titanium, consistent with previous findings [17]. We observed that adhesion capacity gradually increased with increasing scaffold pore size, with cell adhesion rates exceeding 100% for both Ti-95% and Ta-95% groups. Therefore, based on comparisons of ALP activity, Alizarin Red S staining, and cell adhesion capacity, we conclude that tantalum metal scaffolds outperform titanium scaffolds in terms of osseointegration capability, with the advantage being more pronounced at high porosity. Biocompatibility is the foundation for the successful application of implant materials, encompassing cytotoxicity, immunocompatibility, and histocompatibility. Tantalum metal demonstrates excellent performance in these aspects. This implies that tantalum not only promotes cell adhesion and tissue integration but may also reduce infection risks, which is crucial for the long-term survival of the implant. The Wnt/β-catenin signaling pathway is a well-established pathway crucial for regulating cell proliferation, differentiation, and skeletal development. Axin2, Runx2, Sp7, Ctnnb1 (β-catenin), and Bglap are all key molecules within the Wnt signaling pathway [18]. Our experimental results also indicated that tantalum consistently enhanced the activity of Sp7 and Bglap, key mid-to-late osteogenic markers, compared to titanium. While the expression patterns of early pathway components like Axin2 and Ctnnb1 varied between the materials and porosity conditions, the overall osteogenic output, as measured by functional assays and late-stage markers, was superior in tantalum. Bglap, as a terminal marker for evaluating osteogenic differentiation, also suggested superior osteogenic capability for tantalum. High expression of Ptgs2 can promote the early expression of ALP in type I collagen [19]. Although our experiments found that Ptgs2 activity was stronger in titanium than in tantalum, ALP activity expression remained higher for tantalum, further suggesting that tantalum possesses better osteogenic differentiation potential. The Wnt pathway activity indicated good osteogenic capability. Overall bone ingrowth involves both osteoclastic and osteogenic activity. Bone remodeling encompasses both bone resorption and formation. Tnfrsf11 and Tnfrsf11b are important factors in osteoclast function [20]. Our results indicated differing expression patterns for these markers between titanium and tantalum. Tnfrsf11b is suggested to activate the NF-κB and MAPK signaling pathways, while activation of Tnfrsf11 can inhibit osteoclast generation and function. Results for Tnfrsf11 suggested an advantage for tantalum, whereas results for Tnfrsf11b suggested the opposite for titanium. We further utilized the Tnfrsf11 /Tnfrsf11b ratio and found that the bone resorption activity (or the balance) was comparable between the two metals. After demonstrating good osteogenic ability, the inflammatory response of the metal scaffolds is indicative of their potential lifespan. Our assessment of inflammatory markers revealed that both materials could elicit a low inflammatory response under certain conditions (25% and 75% porosity), with Ti scaffolds showing lower IL-1β expression. An interesting finding in this study was that although tantalum performed excellently in most osteogenic indicators, the expression of Runx2, a key early osteogenic transcription factor, peaked in titanium scaffolds with 85% porosity at the 14-day time point. This observation suggests that Ti may exhibit higher Runx2 activity under these specific culture conditions and at this specific time point, potentially indicating a strong early osteogenic response. However, as only a single time point was analyzed, causality and the precise temporal dynamics of Runx2 expression throughout the differentiation process cannot be inferred. The surface properties of the titanium alloy, combined with a specific porous structure (85% porosity), might effectively activate Runx2 via cell adhesion signaling pathways (e.g., integrin-FAK signaling). To confirm whether this represents a genuine and sustained advantage in initiating the osteogenic program, further time-course studies are needed”. However, successful osseointegration requires not only a robust initiation signal but also a microenvironment that supports cell maturation and matrix mineralization. Our data consistently showed that tantalum scaffolds outperformed titanium in indicators representing mid to late-stage osteogenic activity (ALP activity, calcium nodule formation, and Sp7 and Bglap gene expression). This indicates that the bioactive microenvironment provided by tantalum better ensures the progression and completion of the osteogenic differentiation process. This might be more critical for long-term stability than the high expression of a single early-stage gene. Therefore, although titanium showed a specific advantage in the initiation stage, tantalum demonstrated more comprehensive potential in promoting high-quality bone ingrowth. This study is primarily based on in vitro cell experiments. A limited number of existing studies have also demonstrated the advantages of 3D-printed scaffolds [21], indicating that porous prostheses mimicking trabecular bone can promote cell proliferation and differentiation. However, further validation through large animal in vivo experiments is necessary. Additionally, we focused on evaluating biological performance and did not systematically test the mechanical properties (such as elastic modulus and compressive strength) of scaffolds with different pore sizes and porosities. Mechanical performance is another critical consideration for the clinical application of implants. While large pore sizes and high porosity can provide excellent osseointegration potential, the mechanical properties of metal scaffolds change with increasing pore size and porosity. Future studies will integrate in vivo osseointegration models with mechanical analysis to provide a more comprehensive basis for clinical translation. In summary, This reasearch demonstrates that the intrinsic properties of Ta and Ti significantly influence their biological performance beyond the effects of porosity and pore size. Ta exhibits superior overall osteogenic potential and cell adhesion, making it a promising candidate for orthopedic coatings. This direct comparison under identical topological conditions provides crucial insights for selecting and optimizing base materials for prosthetic implants. Supplementary Information Below is the link to the electronic supplementary material.Supplementary file (Docx 46,964 KB) Supplementary file (Docx 46,964 KB)